In this study, we used a PCOS comparator group that was nonobese, non-insulin-resistant and without increased systemic inflammation to address and circumvent the effects of obesity, insulin resistance and inflammation, which are difficult to account for statistically without undermining the effects seen between PCOS subjects and controls. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.